HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A role for the dehydrogenase DHRS7 (SDR34C1) in prostate cancer.

Abstract
Several microarray studies of prostate cancer (PCa) samples have suggested altered expression of the "orphan" enzyme short-chain dehydrogenase/reductase DHRS7 (retSDR4, SDR34C1). However, the role of DHRS7 in PCa is largely unknown and the impact of DHRS7 modulation on cancer cell properties has not yet been studied. Here, we investigated DHRS7 expression in normal human prostate and PCa tissue samples at different tumor grade using tissue microarray and immunovisualization. Moreover, we characterized the effects of siRNA-mediated DHRS7 knockdown on the properties of three distinct human prostate cell lines. We found that DHRS7 protein expression decreases alongside tumor grade, as judged by the Gleason level, in PCa tissue samples. The siRNA-mediated knockdown of DHRS7 expression in the human PCa cell lines LNCaP, BPH1, and PC3 significantly increased cell proliferation in LNCaP cells as well as cell migration in all of the investigated cell lines. Furthermore, cell adhesion was decreased upon DHRS7 knockdown in all three cell lines. To begin to understand the mechanisms underlying the effects of DHRS7 depletion, we performed a microarray study with samples from LNCaP cells treated with DHRS7-specific siRNA. Several genes involved in cell proliferation and adhesion pathways were found to be altered in DHRS7-depleted LNCaP cells. Additionally, genes of the BRCA1/2 pathway and the epithelial to mesenchymal transition regulator E-cadherin were altered following DHRS7 knockdown. Based on these results, further research is needed to evaluate the potential role of DHRS7 as a tumor suppressor and whether its loss-of-function promotes PCa progression and metastasis.
AuthorsJulia K Seibert, Luca Quagliata, Cristina Quintavalle, Thomas G Hammond, Luigi Terracciano, Alex Odermatt
JournalCancer medicine (Cancer Med) Vol. 4 Issue 11 Pg. 1717-29 (Nov 2015) ISSN: 2045-7634 [Electronic] United States
PMID26311046 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2015 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Chemical References
  • RNA, Small Interfering
  • DHRS7 protein, human
  • Oxidoreductases
Topics
  • Cell Adhesion (genetics)
  • Cell Line, Tumor
  • Cell Movement (genetics)
  • Cell Proliferation
  • Cluster Analysis
  • Gene Expression
  • Gene Expression Profiling
  • Gene Knockdown Techniques
  • Humans
  • Immunohistochemistry
  • Male
  • Neoplasm Grading
  • Oxidoreductases (genetics, metabolism)
  • Prognosis
  • Prostatic Neoplasms (genetics, metabolism, mortality, pathology)
  • RNA, Small Interfering (genetics)
  • Transcriptome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: